메뉴 건너뛰기




Volumn 43, Issue 5, 2002, Pages 349-354

Vaccination against foot-and-mouth disease: The implications for Canada

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALUMINUM HYDROXIDE; FOOT AND MOUTH DISEASE VACCINE; INACTIVATED VACCINE; LIVE VACCINE; SAPONIN; VIRUS ANTIGEN; VIRUS VACCINE;

EID: 0036300990     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (27)

References (50)
  • 1
    • 0009723847 scopus 로고    scopus 로고
    • The Commission of the European Communities 2001/257/EC: Commission Decision of 30 March 2001 laying down the conditions for the control and eradication of foot-and-mouth disease in the United Kingdom in of Directive 85/511/EEC (Text with EEA relevance) (notified under document number C 1041). Available at
    • (2001)
  • 2
    • 0009700455 scopus 로고    scopus 로고
    • The Commission of the European Communities 2001/246/EC: Commission Decission of 27 March 2001 laying down the conditions for the control and eradication of foot-and-mouth disease in The Netherlands in application of Directive 85/511/EEC (Text with EEA relevance) (notified under document number C 1018). Official Journal L 088, 28/03/2001. P. 0021-0023. Available at
    • (2001)
  • 3
    • 0009671657 scopus 로고    scopus 로고
    • The Commission of the European Communities 2001/279/EC: Commission Decision of 5 April 2001 amending Decision 2001/246/EC laying down the conditions for the control and eradication of foot-and-mouth disease in application of Article 13 of Directive 85/511/EEC (Text with EEA relevance) (notified under document number C 1070). Official Journal L 096, 06/04/2001, P. 0019-0029. Available at
    • (2001)
  • 4
    • 0009707155 scopus 로고    scopus 로고
    • Office International des Épizooties. Available at: www.oie.int
  • 5
    • 0035942056 scopus 로고    scopus 로고
    • Strategic decisions to evaluate before implementing a vaccine programme in the face of a foot-and-mouth disease (FMD) outbreak
    • (2001) Vet. Rec , vol.148 , pp. 358-360
    • Brownlie, J.1
  • 6
    • 0009675336 scopus 로고    scopus 로고
    • Foreign Animal Disease Unit, Canadian Food Inspection Agency - Animal Health Section: Foot-and-Mouth Disease Strategy (Main) [Web Page]. Aug. Available at
    • (2001)
  • 7
    • 0009708851 scopus 로고    scopus 로고
    • U.K. Department of Environment, Food and Rural Affairs: www.defra.gov.uk/footandmouth/
  • 10
    • 0009700456 scopus 로고    scopus 로고
    • North American Foot-and-Mouth Disease Vaccine Bank: Protocol for the FMD Vaccination Program (updated 9/21/00). Protected information
  • 11
    • 0009669692 scopus 로고    scopus 로고
    • Economic evaluations of the FMD epizootic for agriculture and trade
    • Int. Conf. Control Prev. Foot-and-Mouth Dis. Brussels: 12-13 December Available at: www.cmlag.fgov.be/eng/conference.html
    • (2001)
    • Tomassen, F.1    Mourits, M.2    Huirne, R.3
  • 12
    • 0008477637 scopus 로고
    • Molecular and antigenic analysis of foot-and-mouth disease type C viruses isolated from outbreaks in Italy during 1988 and 1989
    • Proc Res Group Stand Tech Committee Eur Commission Control FMD. Linholm, Denmark
    • (1990) , pp. 122-128
    • Knowles, N.J.1    Samuel, A.R.2
  • 13
    • 0009675022 scopus 로고    scopus 로고
    • Licensing Requirements for Veterinary Biological Products in Canada
    • Canadian Food Inspection Agency. Available at: http://www.inspection.gc.ca/english/anima/vetbio/info/vb323e.shtml
  • 14
    • 0009741342 scopus 로고    scopus 로고
    • Foot-and-mouth disease: Use of vaccine in Canada
    • Discussion paper prepared for the Canadian Food Inspection Agency, August Available at
    • (2001)
    • Sterritt, W.G.1
  • 15
    • 25944439059 scopus 로고    scopus 로고
    • The use of emergency vaccination and the trade implications
    • Int Conf Control Prev Foot-and-Mouth Dis. Brussels, 12-13 December Available at: www.cmlag.fgov.be/eng/conference.html
    • (2001)
    • Pluimers, F.H.1
  • 16
    • 2442617254 scopus 로고    scopus 로고
    • Differentiating infection from vaccination in foot-and-mouth disease
    • (1998) Vet. Q , vol.20 , Issue.SUPPL. 2
    • Mackay, D.K.1
  • 17
    • 0032608731 scopus 로고    scopus 로고
    • Foot-and-mouth disease and beyond: Vaccine design, past, present and future
    • (1999) Arch. Virol. Suppl , vol.15 , pp. 179-188
    • Brown, F.1
  • 18
    • 0012478317 scopus 로고
    • Report of the Committee of Inquiry on Foot-and-Mouth Disease, 1968, Part One
    • Northumberland Report, Part 1 London: Her Majesty's Stationery Office
    • (1968)
  • 22
    • 0345435050 scopus 로고    scopus 로고
    • Optimisation of the immune response to foot-and-mouth disease vaccines
    • (1999) Vaccine , vol.17 , pp. 1767-1771
    • Doel, T.R.1
  • 23
    • 0035968710 scopus 로고    scopus 로고
    • FMD: Chief scientist sets out his views on vaccination
    • (2001) Vet. Rec , vol.149 , pp. 370-371
    • King, D.1
  • 26
    • 0009739943 scopus 로고    scopus 로고
    • Seppic Inc. Montanide ISA; Incomplete Seppic Adjuvants. Fairfield, New Jersey, P/0114/GB/01/February 92
  • 30
    • 0003447768 scopus 로고    scopus 로고
    • Foot-and-mouth disease vaccination: A discussion paper on its use to control outbreaks in Australia
    • Canberra: Bureau of Resource Sciences
    • (1997)
    • Garner, M.G.1    Allen, R.T.2    Short, C.3
  • 31
    • 0009720427 scopus 로고    scopus 로고
    • Canadian Food Inspection Agency - Veterinary Biologics Section: Issuance of Veterinary Biological Products Licence (Main) [Web Page]. Nov. Available at
    • (2001)
  • 32
    • 0009671659 scopus 로고    scopus 로고
    • Canadian Food Inspection Agency - Veterinary Biologics [Web Page]. Nov. Available at
    • (2001)
  • 33
    • 0009698391 scopus 로고    scopus 로고
    • Canadian Food Inspection Agency - Veterinary Biologics [Web Page]. Available at
  • 34
    • 0009723490 scopus 로고    scopus 로고
    • Report at the Annual Meeting of the North American Foot-and-Mouth Disease Vaccine Bank
    • Protected information
    • (2001)
    • Mitzel, J.R.1
  • 35
    • 0009720428 scopus 로고    scopus 로고
    • Reporting suspected adverse reactions/Déclaration des réactions indésirables soupçonnées
    • Canadian Food Inspection Agency. News
    • (1998) Can. Vet. J , vol.39 , pp. 204
  • 36
    • 0009729124 scopus 로고    scopus 로고
    • The use of a 3ABC marker-test for FMD
    • 22nd Conf OIE Reg Commission Asia, the Far East and Oceania, November Available from: Paul.vanAarleιntervet.com
    • (2001)
    • van Aarle, P.1
  • 37
    • 0009741718 scopus 로고    scopus 로고
    • Animal Pharm No. 483 December 21, 2001, p5, PJB Publications Ltd, Available at: www.pjbpubs.com/animal
    • (2001)
  • 38
    • 0009723849 scopus 로고    scopus 로고
    • Socio-economic consequences of FMD for the agricultural sector
    • Int Conf Control Prev Foot-and-Mouth Dis, Brussels, 12-13 December Available at: www.cmlag.fgov.be/eng/conference.html
    • (2001)
    • Hutton, D.1
  • 40
  • 42
    • 0009698392 scopus 로고
    • Foot and Mouth Disease
    • Hubbert WT, McCulloch WF, Schnurrenberger PR, eds. Diseases Transmitted from Animals to Man Springfield, Illinois: Charles C. Thomas
    • (1995)
    • Gustafson, D.P.1
  • 43
    • 0009698393 scopus 로고
    • The susceptibility of man to the virus of foot-and-mouth disease
    • (1952) Vet. Rec , vol.64 , pp. 640-641
    • Betts, A.1
  • 44
    • 84965345325 scopus 로고
    • Foot-and-mouth disease in man
    • (1943) BMJ , vol.1 , pp. 189-190
    • Dlugosz, H.1
  • 45
    • 0009707157 scopus 로고    scopus 로고
    • List of Veterinary Biological Products licensed in Canada - Species: Bovine
    • Canadian Food Inspection Agency. Available at
  • 46
    • 0009675022 scopus 로고    scopus 로고
    • Safety Requirements for Veterinary Biological Products in Canada
    • Canadian Food Inspection Agency. Available at
  • 47
    • 0028884598 scopus 로고
    • Adjuvants for human vaccines - Current status, problems and future prospects
    • (1995) Vaccine , vol.13 , pp. 1263-1276
    • Gupta, R.K.1    Siber, G.R.2
  • 49
    • 0035925666 scopus 로고    scopus 로고
    • The adjuvanted influenza vaccines with novel adjuvants: Experience with the MF-59-adjuvanted vaccine
    • (2001) Vaccine , vol.19 , pp. 2673-2680
    • Podda, A.1
  • 50
    • 0009723850 scopus 로고    scopus 로고
    • Government of Canada. Health of Animals Regulations Part XI, section 134(k). Available


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.